Therapeutics: Means to an end

@article{Novak2004TherapeuticsMT,
  title={Therapeutics: Means to an end},
  author={Krsitine Novak},
  journal={Nature Reviews Cancer},
  year={2004},
  volume={4},
  pages={332-332}
}

References

SHOWING 1-2 OF 2 REFERENCES

Cancer: Survival pathways meet their end

It is proposed that the jugular of cancer-cell survival signalling should be targeted for chemotherapeutic treatment to ensure successful treatment.

Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

It is shown that Akt promotes tumorigenesis and drug resistance by disrupting apoptosis, and that disruption of Akt signalling using the mTOR inhibitor rapamycin reverses chemoresistance in lymphomas expressing Akt, but not in those with other apoptotic defects.